Literature DB >> 9620521

The effect of pneumoperitoneum on intraocular pressure in rabbits with alpha-chymotrypsin-induced glaucoma.

C Lentschener1, J P Leveque, J X Mazoit, D Benhamou.   

Abstract

UNLABELLED: Increased intraperitoneal pressure is associated with physiological changes including alterations of intraocular pressure (IOP). We have previously shown that IOP is not adversely affected by increased intraperitoneal pressure up to 15 mm Hg in women with no preexisting eye disease. The aim of this study was to measure IOP changes associated with increased intraperitoneal pressure (up to 15 mm Hg) of 2 h duration in 12 rabbits with alpha-chymotrypsin-induced glaucoma. A reliable model of glaucoma was created by injecting alpha-chymotrypsin into the posterior chamber of the right eye in 12 rabbits. Thereafter, 5 of the 12 rabbits with glaucomatous eyes were treated with topical timolol. The left eye was used as a control. During pentobarbital general anesthesia, increased intraperitoneal pressure up to 15 mm Hg was created by intraperitoneal CO2 insufflation. Body temperature and expired CO2 were kept constant throughout the study. IOP measurements were made using an electronic pneumotonometer. IOP, mean arterial pressure, heart rate, and central venous pressure were recorded in head-up and head-down positions before, during, and after increased intraperitoneal pressure. The IOP of both eyes, in both treated and untreated rabbits, increased significantly from baseline only when increased intraperitoneal pressure associated with the head-down position resulted in a significant increase in central venous pressure. However, the IOP increase remained within the diurnal range. The major finding of this study is that, in a reliable model of glaucoma, CO2 pneumoperitoneum was associated with an increase in IOP when a head-down position was combined with pneumoperitoneum. IMPLICATIONS: In rabbits with alpha-chymotrypsin-induced glaucoma, increased intraperitoneal pressure (up to 15 mm Hg) resulted in a significant intraocular pressure increase when pneumoperitoneum was associated with the head-down position. However, the intraocular pressure increase remained within the diurnal range.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9620521     DOI: 10.1097/00000539-199806000-00029

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  6 in total

1.  Intraocular pressure variation during colorectal laparoscopic surgery: standard pneumoperitoneum leads to reversible elevation in intraocular pressure.

Authors:  Andrea Grosso; Gitana Scozzari; Fabrizio Bert; Maria Antonietta Mabilia; Roberta Siliquini; Mario Morino
Journal:  Surg Endosc       Date:  2013-04-03       Impact factor: 4.584

2.  Glaucoma in a New Zealand White Rabbit Fed High-cholesterol Diet.

Authors:  Emi Kashiwagi; Koichi Masuno; Kae Fujisawa; Shuuichi Matsushima; Mikinori Torii; Nobuo Takasu
Journal:  J Toxicol Pathol       Date:  2012-03       Impact factor: 1.628

Review 3.  What is the evidence for the use of low-pressure pneumoperitoneum? A systematic review.

Authors:  Denise M D Özdemir-van Brunschot; Kees C J H M van Laarhoven; Gert-Jan Scheffer; Sjaak Pouwels; Kim E Wever; Michiel C Warlé
Journal:  Surg Endosc       Date:  2015-08-15       Impact factor: 4.584

4.  Intraocular Pressure Changes With Positioning During Laparoscopy.

Authors:  Adewale O Adisa; Oluwatoyin H Onakpoya; Anthony T Adenekan; Oluwaseun O Awe
Journal:  JSLS       Date:  2016 Oct-Dec       Impact factor: 2.172

5.  Effects of 25- and 30-degree Trendelenburg positions on intraocular pressure changes during robot-assisted radical prostatectomy.

Authors:  Masatomo Nishikawa; Hiromitsu Watanabe; Tomofumi Kurahashi
Journal:  Prostate Int       Date:  2017-04-07

6.  Prevention of intraocular pressure elevation with oleuropein rich diet in rabbits, during the general anaesthesia.

Authors:  Tuncer Şimşek; Uğur Altınışık; İsmail Erşan; Hasan Şahin; Betül Altınışık; Mesut Erbaş; Çiğdem Pala
Journal:  Springerplus       Date:  2016-07-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.